2020 Updates on tocilizumab indications for clinicians managing patients with severe acute respiratory syndrome coronavirus 2

2020 Updates on tocilizumab indications for clinicians managing patients with severe acute respiratory syndrome coronavirus 2

In March 2020, the World Health Organization declared coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2, as a global pandemic. The number of infected individuals has grown exponentially, and no vaccine candidate is currently available. Hence, various...

Full description

Bibliographic Details
Main Authors: Mohammed A Omair, Waleed Hafiz, Mohammad Mustafa, Leen Ghoniam, Abdulrahman Alreshaid, Ibrahim Almaghlouth, Mazin Barry
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Journal of Nature and Science of Medicine
Subjects:
coronavirus disease 2019
interleukin-6
receptor
tocilizumab
Online Access:http://www.jnsmonline.org/article.asp?issn=2589-627X;year=2020;volume=3;issue=4;spage=344;epage=355;aulast=Omair

Internet

http://www.jnsmonline.org/article.asp?issn=2589-627X;year=2020;volume=3;issue=4;spage=344;epage=355;aulast=Omair

Similar Items